-
Cyclo (-RGDfC) for Reliable Integrin Assays
2026-09-11
This scenario-based guide shows how Cyclo (-RGDfC) (SKU A8790) can help researchers separate αvβ3-mediated adhesion effects from true changes in cell viability. It covers solvent compatibility, assay controls, interpretation of cytotoxicity data, and practical product-selection criteria.
-
Fluorouracil: An Evolution-Aware Assay Strategy
2026-09-11
Fluorouracil and 5-Fluorouracil can reveal more than a single cytotoxicity value. This guide connects thymidylate synthase inhibition with tumor evolution, model selection, time-resolved endpoints, and heterogeneity-aware assay design.
-
PF-562271 HCl: Linking FAK Signaling to CAMLs
2026-09-10
PF-562271 HCl is a selective FAK/Pyk2 inhibitor for dissecting adhesion, migration, and tumor signaling. This article connects its experimentally useful pharmacology with circulating polyploid giant cancer macrophages, while defining what is established, what remains hypothetical, and how to design informative assays.
-
Br-DAPI Workflows for Cardiomyocyte DNA Assays
2026-09-10
Br-DAPI combines selective DNA binding with practical live-cell and fixed-cell imaging for cardiomyocyte injury models. This guide translates diabetic cardiomyopathy findings into reproducible DNA-staining workflows, assay controls, and troubleshooting decisions.
-
Angiotensin 1/2 (5-7) in Translational RAS Research
2026-09-09
A translational guide to using Angiotensin 1/2 (5-7) as a defined renin–angiotensin system reagent, connecting peptide identity, cardiovascular biology, experimental validation, and emerging SARS-CoV-2 spike–receptor research without overstating the evidence.
-
RSL3: GPX4 Inhibitor for Ferroptosis Research
2026-09-09
RSL3 is a selective glutathione peroxidase 4 inhibitor used to induce ferroptosis in cancer research. Its principal value is experimental: it links GPX4-dependent redox failure with lipid peroxidation, oncogenic RAS synthetic lethality, and cancer biology models, but it remains a preclinical research compound.
-
Batimastat (BB-94): From MMPs to NMJ Biology
2026-09-08
Batimastat (BB-94) provides a practical pharmacological lens for studying how matrix metalloproteinase activity shapes extracellular signaling. This thought-leadership perspective connects its established preclinical activity in tumor invasion and angiogenesis with emerging evidence that localized proteolytic processing of muscle-derived BDNF regulates early neuromuscular junction assembly—while clearly separating demonstrated biology from testable translational hypotheses.
-
Fluorouracil (Adrucil): Assay Reliability Guide
2026-09-08
A scenario-based guide to using Fluorouracil (Adrucil), SKU A4071, in cell viability, proliferation, and cytotoxicity assays. It connects mechanism, concentration control, storage, breast and colon cancer research, and vendor-selection decisions to reproducible laboratory workflows.
-
Early Pheromone Sensing and Neurodegeneration
2026-09-07
Peng et al. show that pheromone exposure during the L1 stage of C. elegans can reprogram neurodevelopment and accelerate neurodegeneration in adulthood. Their work identifies a circuit-level mechanism in which ascr#3 and ascr#10 are integrated through ASK, ASI, and AIA neurons, activating insulin-like signaling and suppressing neuronal autophagy.
-
Mitocytosis Targeting in Mitochondrial Cancer Therapy
2026-09-07
Deng and colleagues show that mitocytosis can reduce the antimetastatic benefit of mitochondrial damage, particularly in migrasome-rich 4T1 breast tumors. Their hybrid-membrane nanoplatform combines mitochondria-directed injury with integrin inhibition to exploit and interrupt the route by which damaged mitochondria are expelled.
-
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-09-05
Oliveira et al. show that naturally occurring angiotensin fragments can increase SARS-CoV-2 spike-protein binding to AXL, with shorter and selectively modified peptides producing stronger effects than the precursor angiotensin I. The work connects renin-angiotensin system peptide processing with a receptor-binding mechanism relevant to viral-entry research, while remaining an in vitro binding study rather than evidence of altered clinical infection risk.
-
T7 RNA Polymerase for Reproducible RNA Workflows
2026-09-04
Build cleaner in vitro transcription workflows for research-grade RNA, from linearized plasmids and PCR templates to vaccine-antigen studies, RNAi assays, and structural biology. This guide pairs promoter-aware template design with practical optimization and troubleshooting for T7 RNA Polymerase.
-
Stress Fiber Anisotropy and Gene Regulation
2026-09-04
Wei and colleagues showed that the direction of local mechanical loading can differentially regulate cell stiffness, chromatin deformation, and DHFR transcription through the anisotropic organization of actin stress fibers. Their combination of three-dimensional magnetic twisting cytometry, cytoskeletal perturbation, and discrete mechanical modeling provides a mechanistic framework for linking force mode to gene regulation in living cells.
-
Acetylcholine Chloride: A Causal Assay Framework
2026-09-03
Acetylcholine Chloride can function as a defined perturbation for separating receptor responsiveness from gut microbiota, vagal, and neuronal effects. This article develops a causal assay framework grounded in recent gut-brain epilepsy research and practical product-handling considerations.
-
Anlotinib hydrochloride Assay Guide
2026-09-03
Anlotinib hydrochloride (SKU C8688) offers a data-backed way to study VEGFR2, PDGFRβ, and FGFR1 signaling in endothelial migration, tube formation, viability, and proliferation assays. This scenario-based guide explains dose selection, orthogonal validation, interpretation of potency data, and practical supplier checks.